LY3305677
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY3305677, covering 2017-07-24 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]